Pharmaceutical Product Development, Inc.Wilmington, NC United States
Company Description
Pharmaceutical Product Development (PPD) is on the hunt for newfangled drugs. One of the world's largest contract research organizations (CROs), PPD provides global research and development services to pharmaceutical, biotech, and medical device companies seeking regulatory approval for their products. The CRO offers a broad range of services, from toxicology testing in the earliest phases of drug research, to the management of large, multi-site clinical trials in which drug compounds are tested on human subjects. Its customers have included most of the world's top 50 pharma companies. PPD was acquired in 2011 for some $3.9 billion by private investors
| 929 N. Front St. | Phone: 910-251-0081 | |
| Wilmington, NC 28401 | Fax: 910-762-5820 | |
| United States |
Pharmaceutical Product Development, Inc. Rankings
Executives
| 187 executives listed for Pharmaceutical Product Development, Inc.'s Wilmington, NC location. | ||
| Chairman | Fredric Eshelman | |
|---|---|---|
| COO | William Sharbaugh | |
| CFO, Treasurer, and Assistant Secretary | Daniel Darazsdi | |
Financials
| Company Type | Private - NASDAQ: PPDI Headquarters |
|---|---|
| Fiscal Year-End | December |
| 2010 Employees | 11,000 |
Leverage D&B's credit assessment tools to positively impact
your business. Get the scoop on Pharmaceutical Product Development, Inc. now.
- Reduce risk.
- Drive greater profitability.
- Increase cash flow.
